Department of Otolaryngology - Head and Neck Surgery, Baylor College of Medicine, Houston, Texas, U.S.A.
Laryngoscope. 2024 Jan;134(1):222-227. doi: 10.1002/lary.30844. Epub 2023 Jun 22.
To compare functional outcomes of total laryngectomy (TL) with microvascular free tissue transfer (MVFTT) reconstruction in the treatment of dysfunctional larynx (DL) versus salvage therapy for locally recurrent disease in patients with a history of laryngeal squamous cell carcinoma (SCC).
Retrospective review from a tertiary medical center between August 2015 and August 2022.
Sixty-nine patients underwent TL with MVFTT following primary laryngeal radiation or chemoradiation; 15 (22%) patients underwent functional laryngectomy (FL) and 54 (78%) underwent a salvage laryngectomy (SL). There were no total flap failures. Four (6%) patients developed a pharyngocutaneous fistula; one (7%) FL patient and 3 (6%) in the SL cohort. There was no significant difference in average hospital length of stay (LOS) between the cohorts (8.6 ± 3.0 days vs. 12.8 ± 10.1 days, p = 0.12). All patients (100%) in the FL cohort achieved a total oral diet compared to 41 (76%) in the SL cohort (p = 0.03). Two (13%) and 10 (19%) patients developed pharyngoesophageal stenosis in the FL and SL cohorts, respectively (p = 1.0). Nine (60%) and 23 (43%) patients in the FL and SL cohorts underwent tracheoesophageal puncture (TEP) placement, with 89% and 91% achieving fluency, respectively (p = 0.23).
Although the role of TL for the definitive treatment of laryngeal SCC has decreased over the past 30 years, organ-preservation protocols can impact speech, swallowing, and airway protection with life-threatening consequences. The use of elective FL with MVFTT for the treatment of DL results in similar or better functional outcomes compared to SL for recurrent disease.
3 Laryngoscope, 134:222-227, 2024.
比较全喉切除术(TL)联合游离微血管组织移植(MVFTT)重建与挽救性治疗在喉功能障碍(DL)中的功能结局,以及在有喉鳞状细胞癌(SCC)病史的患者中,局部复发病灶的挽救性治疗。
回顾性分析 2015 年 8 月至 2022 年 8 月期间在一家三级医疗中心进行的研究。
69 例患者因原发性喉放疗或放化疗后接受 TL 联合 MVFTT;15 例(22%)患者行功能喉切除术(FL),54 例(78%)行挽救性喉切除术(SL)。无全皮瓣失败。4 例(6%)患者发生咽皮瘘;1 例(7%)FL 患者和 3 例(6%)SL 患者。两组患者的平均住院时间(LOS)无显著差异(8.6±3.0 天 vs. 12.8±10.1 天,p=0.12)。FL 组所有患者(100%)均实现完全口服饮食,而 SL 组仅 41 例(76%)患者实现(p=0.03)。FL 和 SL 组分别有 2 例(13%)和 10 例(19%)患者发生咽食管狭窄(p=1.0)。FL 和 SL 组分别有 9 例(60%)和 23 例(43%)患者行气管食管造口术(TEP),成功率分别为 89%和 91%(p=0.23)。
尽管全喉切除术作为喉 SCC 确定性治疗的作用在过去 30 年有所下降,但器官保留方案可能会对言语、吞咽和气道保护产生影响,导致危及生命的后果。与复发病灶的挽救性治疗相比,游离微血管组织移植联合选择性 FL 治疗 DL 可获得相似或更好的功能结局。
3 级喉镜,134:222-227,2024。